John F Crowley is Director of Intellia Therapeutics, Inc.. Currently has a direct ownership of 11,716 shares of NTLA, which is worth approximately $173,513. The most recent transaction as insider was on Jun 14, 2023, when has been sold 4,425 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.7K
0% 3M change
0% 12M change
Total Value Held $173,513

John F Crowley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2023
BUY
Grant, award, or other acquisition
-
4,425 Added 27.41%
11,716 Common Stock
Jun 14 2022
BUY
Grant, award, or other acquisition
-
5,197 Added 41.62%
7,291 Common Stock
Oct 11 2021
SELL
Open market or private sale
$298,875 $119.55 p/Share
2,500 Reduced 54.42%
2,094 Common Stock
Oct 11 2021
BUY
Exercise of conversion of derivative security
$47,075 $18.83 p/Share
2,500 Added 35.24%
4,594 Common Stock
Oct 05 2021
SELL
Open market or private sale
$1,308,400 $130.84 p/Share
10,000 Reduced 82.69%
2,094 Common Stock
Oct 05 2021
BUY
Exercise of conversion of derivative security
$188,300 $18.83 p/Share
10,000 Added 45.26%
12,094 Common Stock
Jun 23 2021
BUY
Grant, award, or other acquisition
-
2,094 Added 50.0%
2,094 Common Stock

Also insider at

FOLD
AMICUS THERAPEUTICS, INC. Healthcare
TRDA
Entrada Therapeutics, Inc. Healthcare
JFC

John F Crowley

Director
Boston, MA

Track Institutional and Insider Activities on NTLA

Follow Intellia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTLA shares.

Notify only if

Insider Trading

Get notified when an Intellia Therapeutics, Inc. insider buys or sells NTLA shares.

Notify only if

News

Receive news related to Intellia Therapeutics, Inc.

Track Activities on NTLA